Skip to main content
Clinical Trials/JPRN-jRCTs031180293
JPRN-jRCTs031180293
Recruiting
Phase 2

Clinical trial for investigating the efficacy and safety of PICIBANIL (OK-432) for pleurodesis against pulmonary fistula - refractory pneumothorax or postoperative air leakage

Ohtaki Yoichi0 sites80 target enrollmentMarch 15, 2019

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Refractory pneumothorax and postoperative lung fistula
Sponsor
Ohtaki Yoichi
Enrollment
80
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 15, 2019
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Ohtaki Yoichi

Eligibility Criteria

Inclusion Criteria

  • 1\) patient with refractory pneumothorax or postoperative lung fistula
  • 2\) patient with intrathoracic drain
  • 3\) hospitalized patient
  • 4\) patient with written consent

Exclusion Criteria

  • 1\) patient with past history of allergy to Picibanil or penicillin\-based antibiotic
  • 2\) patient that were judged unsuitable by the treating doctor

Outcomes

Primary Outcomes

Not specified

Similar Trials